Will FDA approve any mRNA vaccine against myeloid leukemia before 2028?
Mini
5
155
2027
34%
chance

Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of myeloid leukemia in the United States before January 1, 2028. This does not include emergency use authorization or other forms of limited authorization. Resolves NO otherwise.

Get Ṁ600 play money